SANGAMO THERAPEUTICS, INC
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On June 28, 2021, Gary H. Loeb, Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer of Sangamo Therapeutics, Inc. (the “Company”), notified the Company of his resignation from these positions and from his employment with the Company, in each case to be effective on July 16, 2021, in order to pursue a new opportunity.
Extracted from this filing and checked against the source text.
Gary H. Loeb resigned as Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer at SANGAMO THERAPEUTICS, INC.
On June 28, 2021, Gary H. Loeb, Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer of Sangamo Therapeutics, Inc. (the “Company”), notified the Company of his resignation from these positions and from his employment with the Company, in each case to be effective on July 16, 2021, in order to pursue a new opportunity.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.